S Brugueras1, À Orcau2, J-P Millet3, L Espinosa4, A de Andrés1, P Gorrindo1, J A Caylà3. 1. Epidemiology Service, Public Health Agency of Barcelona, Barcelona. 2. Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Centros de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid. 3. Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Centros de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Tuberculosis Investigation Unit of Barcelona, Barcelona. 4. Barcelona Health Consortium, Barcelona, Spain.
Abstract
INTRODUCTION: The Barcelona Tuberculosis Programme was established in 1987, and in 2007 five tuberculosis (TB) clinical units were created to improve the follow-up of cases and contacts. This included the designation of a nurse for case management. OBJECTIVE: To assess the impact of the TB clinical units on the screening programme for TB contacts. METHODS: Before-after population-based study before (2003-2007) and after (2008-2013) the creation of the clinical units. To determine which factors were related to contact tracing, we fitted a multivariate logistic regression model to estimate odds ratios (OR) with their 95% confidence intervals (CIs). RESULTS: Following the creation of the clinical units, the proportion of prescriptions for latent tuberculous infection among contacts in the clinical units increased from 40.7% to 57.4% (P < 0.001), and treatment adherence from 75.9% to 80.3% (P = 0.035). One factor associated with contact tracing was receiving care after the creation of the clinical units (2008-2013) (OR 1.2, 95%CI 1.0-1.3). During the second period, receiving care outside the clinical units reduced the probability of contact tracing (OR 0.7, 95%CI 0.5-0.9). CONCLUSION: The creation of the TB clinical units represents an organisational improvement for the study and management of contacts of patients with TB.
INTRODUCTION: The Barcelona Tuberculosis Programme was established in 1987, and in 2007 five tuberculosis (TB) clinical units were created to improve the follow-up of cases and contacts. This included the designation of a nurse for case management. OBJECTIVE: To assess the impact of the TB clinical units on the screening programme for TB contacts. METHODS: Before-after population-based study before (2003-2007) and after (2008-2013) the creation of the clinical units. To determine which factors were related to contact tracing, we fitted a multivariate logistic regression model to estimate odds ratios (OR) with their 95% confidence intervals (CIs). RESULTS: Following the creation of the clinical units, the proportion of prescriptions for latent tuberculous infection among contacts in the clinical units increased from 40.7% to 57.4% (P < 0.001), and treatment adherence from 75.9% to 80.3% (P = 0.035). One factor associated with contact tracing was receiving care after the creation of the clinical units (2008-2013) (OR 1.2, 95%CI 1.0-1.3). During the second period, receiving care outside the clinical units reduced the probability of contact tracing (OR 0.7, 95%CI 0.5-0.9). CONCLUSION: The creation of the TB clinical units represents an organisational improvement for the study and management of contacts of patients with TB.
Authors: Mario Martin-Sanchez; Silvia Brugueras; Anna de Andrés; Pere Simon; Pilar Gorrindo; Miriam Ros; Eva Masdeu; Joan-Pau Millet; Joan A Caylà; Àngels Orcau Journal: PLoS One Date: 2019-04-15 Impact factor: 3.240